Published 6 days ago • loading... • Updated 6 days ago
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The awards include options for up to 296,500 shares and restricted stock units covering 94,100 shares, the company said.
Summary by WBOC 16
6 Articles
6 Articles
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA) ('Aura” or the 'Company”), a clinical-stage biotechnology company developing precision therapies...
Coverage Details
Total News Sources6
Leaning Left0Leaning Right1Center2Last Updated67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium


